Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

TAVR still a safe treatment option for immunocompromised patients
While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues. This new meta-analysis explored data from a variety of clinical trials.
Pope welcomes cardiologists to Vatican City
Pope Leo XIV told interventional cardiologists their work “stands at the crossroads of science, compassion and ethical responsibility.” When they treat patients, he added, they are treating the heart “both physically and metaphorically, bringing relief to those who suffer.”
Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR
The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.
FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public
The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.
Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.

Medtronic relaunches Harmony TPV system after 2022 recall

The device, which gained FDA approval in 2021, was part of a voluntary recall in 2022 due to stability concerns. Medtronic worked with the FDA to address the issue, and the Harmony TPV is once again available throughout the United States.

Focused ultrasound reduces physical symptoms of Parkinson's disease

Given the less invasive nature of focused ultrasound procedures, researchers suggest that it could open the door for disease management options catered to a wider variety of patients.

New patient-specific heart models could change how cardiologists make treatment decisions

The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions.

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications.

Tim Attebery, DSc, MBA, the CEO of Cardiovascular Associates of America and former CEO of the American College of Cardiology (ACC)

Q&A: Tim Attebery on why private equity-backed management companies are investing in cardiology

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.

New ACC/AHA/SCAI guidance highlights training requirements for interventional cardiologists

The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies.

Virtual learning left some radiology residents feeling uncomfortable completing procedures

Some residents recently indicated that virtual learning environments led them to having little-to-no procedural training at all in certain subspecialties.

The increased use of implantable loop recorders (ILRs) is associated with identifying more bradyarrhythmias such as bradycardia, according to new findings published in JAMA Cardiology.

Increased AFib screening improves bradyarrhythmia detection—but is it a mixed blessing?

When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value?

Clinical

TAVR still a safe treatment option for immunocompromised patients

Pope welcomes cardiologists to Vatican City

Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M